Physician profile
Gerald N Kadis
NPI 1942388087
$2,179.35
in general payments reported to CMS, 2019-2025
20 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $98.75 · 2021: $89.53 · 2022: $247 · 2023: $289 · 2024: $557 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $369.63 | 2019-2024 | Senza |
| Stryker Corporation | $295.62 | 2019-2023 | Avs Navigator |
| Astrazeneca Pharmaceuticals LP | $230.30 | 2022-2024 | Andexxa |
| Titan Spine, LLC | $230.24 | 2019 | |
| Novocure INC. | $178.62 | 2019-2024 | Optune |
| Globus Medical, INC. | $157.00 | 2019-2025 | Senza |
| Abbott Laboratories | $150.72 | 2020-2024 | Eterna, Proclaim |
| Medtronic, INC. | $126.43 | 2024-2025 | Mazor X System, Inceptiv |
| Integra Lifesciences Corporation | $118.09 | 2023-2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Aesculap, INC. | $67.35 | 2023 | Aesculap |
| Kyocera Medical Technologies, INC. | $60.33 | 2023 | |
| Arkis Biosciences INC | $44.68 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $35.52 | 2019-2025 | Exparel |
| Kci USA, INC. | $24.50 | 2023 | Prevena |
| Arteriocyte Medical Systems, INC. | $24.28 | 2023 | Magellan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.29 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.83 | 2019 | |
| Bioventus LLC | $15.20 | 2022 | |
| Wenzel Spine, INC. | $13.45 | 2023 | Varilift |
| Kls-Martin L.P. | $4.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Kadis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.